Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Journal of Psychoactive Drugs|March 2, 2023
Ketamine-Assisted Group Psychotherapy for Frontline Healthcare Workers with COVID-19-Related Burnout and PTSD: A Case Series of Effectiveness/Safety for 10 ParticipantsReid Robison, Madeline Brendle, Claire Moore, et al.Cold Spring Harbor Molecular Case Studies|December 1, 2016
KBG syndrome involving a single-nucleotide duplication in ANKRD11Robert Kleyner, Janet Malcolmson, David Tegay, et al.Brain Sciences|March 25, 2022
Ketamine as a Novel Psychopharmacotherapy for Eating Disorders: Evidence and Future DirectionsAnya Ragnhildstveit, Matthew Slayton, Laura Kate Jackson, et al.BMC Medical Genomics|February 24, 2017
Whole genome sequencing of one complex pedigree illustrates challenges with genomic medicineHan Fang, Yiyang Wu, Hui Yang, et al.Peerj|October 11, 2013
Integrating precision medicine in the study and clinical treatment of a severely mentally ill personJason A O'Rawe, Han Fang, Shawn Rynearson, et al.Cold Spring Harbor Molecular Case Studies|December 1, 2016
SCN8A mutation in a child presenting with seizures and developmental delaysJanet Malcolmson, Robert Kleyner, David Tegay, et al.Frontiers in Psychiatry|February 27, 2023
Cannabis-assisted psychotherapy for complex dissociative posttraumatic stress disorder: A case reportAnya Ragnhildstveit, Miriam Kaiyo, Matthew Brian Snyder, et al.JAMA|September 4, 2025
Single Treatment With MM120 (Lysergide) in Generalized Anxiety Disorder: A Randomized Clinical TrialReid Robison, Robert Barrow, Craig Conant, et al.American Journal of Human Genetics|June 25, 2011
Using VAAST to identify an X-linked disorder resulting in lethality in male infants due to N-terminal acetyltransferase deficiencyAlan F Rope, Kai Wang, Rune Evjenth, et al.JAMA|August 31, 2023
Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical TrialCharles L Raison, Gerard Sanacora, Joshua Woolley, et al.Pageof 3